Cargando…

CA-125 Early Dynamics to Predict Overall Survival in Women with Newly Diagnosed Advanced Ovarian Cancer Based on Meta-Analysis Data

SIMPLE SUMMARY: Cancer antigen 125 (CA-125) is a protein found at a high concentration in the blood of patients with specific types of cancer, mainly ovarian cancer. In 2004, the Gynecologic Cancer Intergroup (GCIG) proposed criteria defining response to treatment, as well as disease progression, ba...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karamouza, Eleni, Glasspool, Rosalind M., Kelly, Caroline, Lewsley, Liz-Anne, Carty, Karen, Kristensen, Gunnar B., Ethier, Josee-Lyne, Kagimura, Tatsuo, Yanaihara, Nozomu, Cecere, Sabrina Chiara, You, Benoit, Boere, Ingrid A., Pujade-Lauraine, Eric, Ray-Coquard, Isabelle, Proust-Lima, Cécile, Paoletti, Xavier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047009/ https://www.ncbi.nlm.nih.gov/pubmed/36980708 http://dx.doi.org/10.3390/cancers15061823

Ejemplares similares

Assessment of Progression-Free Survival as a Surrogate End Point of Overall Survival in First-Line Treatment of Ovarian Cancer: A Systematic Review and Meta-analysis
por: Paoletti, Xavier, et al.
Publicado: (2020)

Bevacizumab and oral metronomic cyclophosphamide in platinum-resistant ovarian cancer
por: Pujade-Lauraine, Eric
Publicado: (2013)

Prediction of tumour response induced by chemotherapy using modelling of CA-125 kinetics in recurrent ovarian cancer patients
por: Wilbaux, M, et al.
Publicado: (2014)

Olaparib as maintenance treatment for patients with platinum-sensitive relapsed ovarian cancer
por: Ledermann, Jonathan A., et al.
Publicado: (2019)

CA-125 can be part of the tumour evaluation criteria in ovarian cancer trials: experience of the GCIG CALYPSO trial
por: Alexandre, J, et al.
Publicado: (2012)

Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis
por: Ethier, Josee-Lyne, et al.
Publicado: (2017)

Everolimus as second- or third-line treatment of advanced endometrial cancer: ENDORAD, a phase II trial of GINECO
por: Ray-Coquard, I, et al.
Publicado: (2013)

Update on rare epithelial ovarian cancers: based on the Rare Ovarian Tumors Young Investigator Conference
por: Jang, Ji Yon Agnes, et al.
Publicado: (2017)

Cardiovascular Toxicity of Multi-Tyrosine Kinase Inhibitors in Advanced Solid Tumors: A Population-Based Observational Study
por: Srikanthan, Amirrtha, et al.
Publicado: (2015)

Intensified dose of cyclophosphamide with G-CSF support versus standard dose combined with platinum in first-line treatment of advanced ovarian cancer a randomised study from the GINECO group
por: Ray-Coquard, I, et al.
Publicado: (2007)

Neoadjuvant and Adjuvant Systemic Therapy for Newly Diagnosed Stage II–IV Epithelial Ovary, Fallopian Tube, or Primary Peritoneal Carcinoma: A Practice Guideline
por: Hirte, Hal, et al.
Publicado: (2022)

High Expression of HLA-G in Ovarian Carcinomatosis: The Role of Interleukin-1β
por: Ullah, Matti, et al.
Publicado: (2019)

Part I of GANNET53: A European Multicenter Phase I/II Trial of the Hsp90 Inhibitor Ganetespib Combined With Weekly Paclitaxel in Women With High-Grade, Platinum-Resistant Epithelial Ovarian Cancer—A Study of the GANNET53 Consortium
por: Ray-Coquard, Isabelle, et al.
Publicado: (2019)

A longitudinal analysis with CA-125 to predict overall survival in patients with ovarian cancer
por: Chiang, An Jen, et al.
Publicado: (2014)

Prognostic significance of serum CA125 in the overall management for patients with gastrointestinal stromal tumors
por: Sui, Chao, et al.
Publicado: (2023)

Normalized LST Is an Efficient Biomarker for Homologous Recombination Deficiency and Olaparib Response in Ovarian Carcinoma
por: Christinat, Yann, et al.
Publicado: (2023)

Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial
por: Oza, Amit M, et al.
Publicado: (2015)

Correction to: Prognostic significance of serum CA125 in the overall management for patients with gastrointestinal stromal tumors
por: Sui, Chao, et al.
Publicado: (2023)

Systematic analysis of circulating soluble angiogenesis-associated proteins in ICON7 identifies Tie2 as a biomarker of vascular progression on bevacizumab
por: Zhou, Cong, et al.
Publicado: (2016)

Shallow whole genome sequencing approach to detect Homologous Recombination Deficiency in the PAOLA-1/ENGOT-OV25 phase-III trial
por: Callens, Celine, et al.
Publicado: (2023)

Surgical Implications of Advanced Low-Grade Serous Ovarian Cancer: Analysis of the Database of the Tumeurs Malignes Rares Gynécologiques Network
por: Bonsang-Kitzis, Hélène, et al.
Publicado: (2022)

Major determinants for the selecting antithrombotic therapies in patients with nonvalvular atrial fibrillation in Japan (JAPAF study)
por: Kusakawa, Koichi, et al.
Publicado: (2017)

Significance of 1,25-Dihydroxyvitamin D(3) on Overall Mortality in Peritoneal Dialysis Patients with COVID-19
por: Baralić, Marko, et al.
Publicado: (2023)

Sexual Intercourse Among High School Students — 29 States and United States Overall, 2005–2015
por: Ethier, Kathleen A., et al.
Publicado: (2018)

Olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer: Japan subset from the PAOLA-1/ENGOT-ov25 trial
por: Fujiwara, Keiichi, et al.
Publicado: (2021)

Factors Associated with Long-Term Use of Hypnotics among Patients with Chronic Insomnia
por: Takaesu, Yoshikazu, et al.
Publicado: (2014)

MicroRNA Gene Expression Signature Driven by miR-9 Overexpression in Ovarian Clear Cell Carcinoma
por: Yanaihara, Nozomu, et al.
Publicado: (2016)

Proportions and incidence of locally advanced cervical cancer: a global systematic literature review
por: Monk, Bradley J, et al.
Publicado: (2022)

Left Ventricular Ejection Fraction in Patients With Ovarian Cancer Treated With Avelumab, Pegylated Liposomal Doxorubicin, or Both
por: Bonaca, Marc P, et al.
Publicado: (2023)

Photocatalytic Overall Water Splitting over MIL‐125(Ti) upon CoPi and Pt Co‐catalyst Deposition
por: An, Yang, et al.
Publicado: (2017)

Tablet terminals: a useful tool to explain in vitro fertilization treatment
por: Yanaihara, Atsushi, et al.
Publicado: (2017)

Clinical Features and Treatment Modes of Mandibular Fracture at the Department of Oral and Maxillofacial Surgery, Shimane University Hospital, Japan
por: Tatsumi, Hiroto, et al.
Publicado: (2015)

Design and baseline characteristics of the LANDMARK study
por: Ogata, Hiroaki, et al.
Publicado: (2016)

A case of relapsing aseptic meningitis under excellent tumor response to pembrolizumab in microsatellite instability-high recurrent endometrial cancer
por: Noguchi, Daito, et al.
Publicado: (2021)

CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer—A Multicenter Analysis
por: Wohlmuth, Christoph, et al.
Publicado: (2022)

Gemcitabine-oxaliplatin combination for ovarian cancer resistant to taxane-platinum treatment: a phase II study from the GINECO group
por: Ray-Coquard, I, et al.
Publicado: (2009)

Oral Ketamine vs Placebo in Patients With Cancer-Related Neuropathic Pain: A Randomized Clinical Trial
por: Fallon, Marie T., et al.
Publicado: (2018)

Lack of relationship between EGFR-1 immunohistochemical expression and prognosis in a multicentre clinical trial of 93 patients with advanced primary ovarian epithelial cancer (GINECO group)
por: Elie, C, et al.
Publicado: (2004)

The Coefficient of Variation of Red Blood Cell Distribution Width Combined with Cancer Antigen 125 Predicts Postoperative Overall Survival in Endometrial Cancer
por: Zhong, Wenhui, et al.
Publicado: (2021)

MicroRNA-21 is a candidate driver gene for 17q23-25 amplification in ovarian clear cell carcinoma
por: Hirata, Yukihiro, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_08380e0tk9t05ii39nf5q8ecjl